Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Metastasis | ASO Author Reflections

ASO Author Reflections: Resection for Metastasis to the Pancreas—Worthwhile for Selected Patients

Authors: Qiuyi Huang, MD, Haiyang Zhou, MD, Chen Liu, MD, Xianjun Yu, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

Metastatic lesions to the pancreas are uncommon, only accounting for 2% of all pancreatic neoplasms.1 Although most literature justifies metastasectomy, especially the resection of metastatic lesions of liver, lung, and brain, the effectiveness of pancreatic metastasectomy remains unclear. There is no prospective, randomized or case-controlled study evaluating the role of pancreatic metastasectomy, probably because of the rarity of this condition and the limited sample size. The majority of existing retrospective studies as well as case reports claim that compared with nonoperative treatment, pancreatic metastasectomy has a trend to prolong survival.2,3 So far, no evidence-based guideline for the management of this condition exists. …
Literature
1.
Sperti C, Pasquali C, Liessi G, Pinciroli L, Decet G, Pedrazzoli S. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol. 2003;83(3):161–6; discussion 166CrossRef
2.
Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol. 2008;15(4):1161–8.CrossRef
3.
Adler H, Redmond CE, Heneghan HM, et al. Pancreatectomy for metastatic disease: a systematic review. Eur J Surg Oncol. 2014;40(4):379–86.CrossRef
4.
Huang Q-Y, Zhou H-Y, Liu C, Jin K-Z, et al. Surgical resection for metastatic tumors in the pancreas: a single-center experience and systematic review. Ann Surg Oncol. 2019;26:1649–56.CrossRef
Metadata
Title
ASO Author Reflections: Resection for Metastasis to the Pancreas—Worthwhile for Selected Patients
Authors
Qiuyi Huang, MD
Haiyang Zhou, MD
Chen Liu, MD
Xianjun Yu, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Keyword
Metastasis
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07621-3

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue

ASO Author Reflections

ASO Author Reflections: Clarifying the Controversy Generated by Non-inferiority Trials of Laparoscopic Surgery for Rectal Cancer

ASO Author Reflections

ASO Author Reflections: Resolving the Challenges in the Management of Mammary Phyllodes Tumor

ASO Author Reflections

ASO Author Reflections: Lymph Node Metastasis and the Role for Lymphadenectomy During Surgery for Nonfunctional Pancreatic Neuroendocrine Tumors

ASO Author Reflections

ASO Author Reflections: Use of the Survival Recurrent Network for Prediction of Overall Survival in Patients with Gastric Cancer

ASO Author Reflections

ASO Author Reflections: Late-Term Toxicity After Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumor Underscores the Need for Novel Drug Development and Clinical Trial Design

ASO Author Reflections

ASO Author Reflections: The Accurate Prognostic Evaluation and Optimal Treatment Strategy for Ampulla of Vater Carcinoma